SavedAdd your journal

Journals / Neurological sciences and neurophysiology (Online) / 2020 / Cilt: 37 - Sayı: 1

COVID‑19 Associate Neurological Complications

Leyla BAYSAL-KIRAÇ
Hilmi UYSAL
Pages
1–3
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Heath‑care providers should be aware that COVID‑19 can associate neurological manifestations.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:2019‑novel Coronavirus disease (COVID‑19) is a global health problem that affected >2.000.000 people in the world.
📊
Key Findings & Data:In this short review, we would like to draw attention to COVID‑19‑related neurological symptoms.
💡
Conclusion & Impact:Heath‑care providers should be aware that COVID‑19 can associate neurological manifestations.
🔬Design:Review & Systematic Survey
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Özet

2019‑novel Coronavirus disease (COVID‑19) is a global health problem that affected >2.000.000 people in the world. Although the main component of the disease is pulmonary disturbances, recent reports suggested neurological manifestations. Neurological complications have been rarely reported with other Coronavirus associated diseases. In this short review, we would like to draw attention to COVID‑19‑related neurological symptoms. Heath‑care providers should be aware that COVID‑19 can associate neurological manifestations.

🔖

Cite This Article

BAYSAL-KIRAÇ, L., UYSAL, H. (2020). COVID‑19 Associate Neurological Complications. Neurological sciences and neurophysiology (Online), Cilt: 37 - Sayı: 1, 1–3. https://ajindex.com/articles/290523

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Weintraub D, Hoops S, Shea JA, Lyons KE, Pahwa R, Driver‑Dunckley ED, et al. Validation of the questionnaire for impulsive‑compulsive disorders in Parkinson’s disease. Mov Disord 2009;24:1461‑7
  2. Weintraub D, Siderowf AD, Potenza MN, Goveas J, Morales KH, Duda JE, et al. Association of dopamine agonist use with impulse control disorders in Parkinson disease. Arch Neurol 2006;63:969‑73
  3. Evans AH, Lawrence AD, Potts J, Appel S, Lees AJ. Factors influencing susceptibility to compulsive dopaminergic drug use in Parkinson disease. Neurology 2005;65:1570‑4
  4. Gallagher DA, O’Sullivan SS, Evans AH, Lees AJ, Schrag A. Pathological gambling in Parkinson’s disease: Risk factors and differences from dopamine dysregulation. An analysis of published case series. Mov Disord 2007;22:1757‑63
  5. Rossi M, Gerschcovich ER, de Achaval D, Perez‑Lloret S, Cerquetti D, Cammarota A, et al. Decision‑making in Parkinson’s disease patients with and without pathological gambling. Eur J Neurol 2010;17:97‑102
  6. Voon V, Pessiglione M, Brezing C, Gallea C, Fernandez HH, Dolan RJ, et al. Mechanisms underlying dopamine‑mediated reward bias in compulsive behaviors. Neuron 2010;65:135‑42
  7. Evens R, Hoefler M, Biber K, Lueken U. The Iowa Gambling Task in Parkinson’s disease: A meta‑analysis on effects of disease and medication. Neuropsychologia 2016;91:163‑72
  8. Cools R, Barker RA, Sahakian BJ, Robbins TW. L‑Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson’s disease. Neuropsychologia 2003;41:1431‑41
  9. Poletti M, Frosini D, Lucetti C, Del Dotto P, Ceravolo R, Bonuccelli U. Decision making in de novo Parkinson’s disease. Mov Disord 2010;25:1432‑6
  10. Kobayakawa M, Koyama S, Mimura M, Kawamura M. Decision making in Parkinson’s disease: Analysis of behavioral and physiological patterns in the Iowa Gambling Task. Mov Disord 2008;23:547‑52
  11. Frank MJ, Seeberger LC, O’reilly RC. By carrot or by stick: Cognitive reinforcement learning in Parkinsonism. Science 2004;306:1940‑3
  12. Claassen DO, van den Wildenberg WPM, Ridderinkhof KR, Jessup CK, Harrison MB, Wooten GF, et al. The risky business of dopamine agonists in Parkinson disease and impulse control disorders. Behav Neurosci 2011;125:492‑500
  13. Folstein MF, Folstein SE, McHugh PR. “Mini‑mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189‑98
  14. Hamilton M. A rating scale for depression. J Neurol